RS56228609 Unknown gene
Upload your DNA to see your genotype for this variant.
GWAS Studies (20)
| Trait | Risk Allele | OR / Beta | P-value | Study |
|---|---|---|---|---|
| Phospholipids to Total Lipids in Very Large VLDL percentage | T | OR: 0.14 | 5E-474 | PubMed |
| Phospholipids to Total Lipids in Very Large VLDL percentage | T | OR: 0.11 | 5E-239 | PubMed |
| CETP protein levels | — | OR: 0.54 | 5E-59 | PubMed |
| Protein Wnt-5a levels | T | OR: 0.2 | 6E-44 | PubMed |
| IFNGR2 protein levels | T | β: 0.04 | 2E-26 | PubMed |
| 1-(1-enyl-palmitoyl)-2-linoleoyl-GPC (P-16:0/18:2) levels | T | OR: 0.12 | 1E-25 | PubMed |
| HDL cholesterol levels | C | OR: 0.21 | 3E-24 | PubMed |
| 1-(1-enyl-palmitoyl)-2-arachidonoyl-gpc (p-16:0/20:4) levels | T | OR: 0.1 | 5E-20 | PubMed |
| Protein FAM177A1 levels | T | OR: 0.13 | 4E-19 | PubMed |
| LDL x depression interaction (2df test) | T | OR: 0.93 | 4E-15 | PubMed |
| NOTCH3 protein levels | T | β: 0.04 | 5E-15 | PubMed |
| 1,2-dipalmitoyl-gpc (16:0/16:0) levels | T | β: 0.081 | 7E-14 | PubMed |
| Polyunsaturated fatty acids to monounsaturated fatty acids ratio | T | — | 2E-13 | PubMed |
| Polyunsaturated fatty acids to monounsaturated fatty acids ratio | T | — | 5E-13 | PubMed |
| Plasma 1-(1-enyl-palmitoyl)-2-palmitoyl-GPC (P-16:0/16:0)* levels in chronic kidney disease | T | β: 0.059 | 3E-12 | PubMed |
| 1-(1-enyl-palmitoyl)-2-docosahexaenoyl-GPC (P-16:0/22:6) levels | T | β: 0.067 | 9E-10 | PubMed |
| Cholesteryl ester (18:0) levels | T | OR: 0.15 | 1E-9 | PubMed |
| Omega-3 fatty acids levels | T | β: 0.026 | 1E-9 | PubMed |
| Alkylphosphatidylcholine (O-16:0/16:0) levels | T | OR: 0.15 | 1E-9 | PubMed |
| Ratio of 22:6 docosahexaenoic acid to total fatty acids | T | β: 0.026 | 2E-9 | PubMed |